Therefore, therapeutic methods to manage the neurological disorder involve the modulation of the activity of BACE1 (Beta-site Amyloid Precursor Cleaving Enzyme 1), NMDAR (N-Methyl-D-aspartate Receptors), dopamine receptors, and inhibition of cholinesterase enzymes, AChE and BChE, and imparting better cholinergic functions of the brain. Here, BCHE is linked to nervous system disorder.